These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. All eyes on a hurdle race for a SARS-CoV-2 vaccine. Gaebler C; Nussenzweig MC Nature; 2020 Oct; 586(7830):501-502. PubMed ID: 33077943 [No Abstract] [Full Text] [Related]
10. The Challenges of Vaccine Development against a New Virus during a Pandemic. Diamond MS; Pierson TC Cell Host Microbe; 2020 May; 27(5):699-703. PubMed ID: 32407708 [TBL] [Abstract][Full Text] [Related]
11. Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial. Usmani SS; Raghava GPS Front Immunol; 2020; 11():561851. PubMed ID: 33133071 [No Abstract] [Full Text] [Related]
12. The COVID-19 vaccine development landscape. Thanh Le T; Andreadakis Z; Kumar A; Gómez Román R; Tollefsen S; Saville M; Mayhew S Nat Rev Drug Discov; 2020 May; 19(5):305-306. PubMed ID: 32273591 [No Abstract] [Full Text] [Related]
13. Covid-19 and the race for a vaccine. Cueto M Hist Cienc Saude Manguinhos; 2020; 27(3):715-717. PubMed ID: 33111785 [No Abstract] [Full Text] [Related]
14. Vaccine Development Against COVID-19 Prior to Pandemic Outbreaks, Using Zayed H Front Immunol; 2020; 11():2051. PubMed ID: 32922408 [No Abstract] [Full Text] [Related]
15. Understanding COVID-19 vaccine efficacy. Lipsitch M; Dean NE Science; 2020 Nov; 370(6518):763-765. PubMed ID: 33087460 [No Abstract] [Full Text] [Related]
16. COVID-19 and Bacillus Calmette-Guérin: What is the Link? Hegarty PK; Sfakianos JP; Giannarini G; DiNardo AR; Kamat AM Eur Urol Oncol; 2020 Jun; 3(3):259-261. PubMed ID: 32327396 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines. Salvatori G; Luberto L; Maffei M; Aurisicchio L; Roscilli G; Palombo F; Marra E J Transl Med; 2020 Jun; 18(1):222. PubMed ID: 32493510 [TBL] [Abstract][Full Text] [Related]
18. Demand for BCG Vaccine Due to Unproven Claims of its Role in Preventing COVID-19 Is Causing Shortages of Vaccines for Infants in Japan. Kuroda N Pediatr Infect Dis J; 2020 Jul; 39(7):e159-e160. PubMed ID: 32379194 [No Abstract] [Full Text] [Related]
19. Why do SARS-COV vaccines not exist? The pharma scientific intelligence and business model must be revisited! Boudjelal M; Nehdi A; Islam I Expert Opin Drug Discov; 2020 Nov; 15(11):1233-1235. PubMed ID: 32543297 [No Abstract] [Full Text] [Related]
20. A vaccine is not too far for COVID-19. Patel SK; Pathak M; Tiwari R; Yatoo MI; Malik YS; Sah R; Rabaan AA; Sharun K; Dhama K; Bonilla-Aldana DK; Rodriguez-Morales AJ J Infect Dev Ctries; 2020 May; 14(5):450-453. PubMed ID: 32525830 [No Abstract] [Full Text] [Related] [Next] [New Search]